BF Biosciences Limited (PSX:BFBIO)
157.27
-6.74 (-4.11%)
At close: Feb 19, 2026
BF Biosciences Market Cap
BF Biosciences has a market cap or net worth of 13.89 billion as of February 19, 2026. Its market cap has decreased by -26.31% in one year.
Market Cap
13.89B
Enterprise Value
14.06B
Revenue
6.88B
Ranking
n/a
PE Ratio
27.90
Stock Price
157.27
Market Cap Chart
Since October 22, 2024, BF Biosciences's market cap has increased from 7.41B to 13.89B, an increase of 87.54%. That is a compound annual growth rate of 60.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 13.89B | 11.92% |
| Dec 31, 2025 | 12.41B | -40.17% |
| Dec 31, 2024 | 20.75B | 180.05% |
| Oct 22, 2024 | 7.41B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avanceon | 16.46B |
| Fast Cables | 16.46B |
| Ittehad Chemicals | 15.69B |
| Archroma Pakistan | 15.31B |
| Jubilee General Insurance Company | 15.29B |
| MCB investment management | 15.27B |
| Macter International | 15.18B |
| Century Paper & Board Mills | 14.99B |